UnknownPhase 4ketamine

Optimal Multimodal Analgesia in Laparoscopic Cholecystectomy

NCT ID

NCT00209885

Target Enrollment

60 participants

Start Date

2005-10

About This Study

To test the current standard of care (SOC) treatment for laparoscopic cholecystectomy with a group receiving SOC + additional perioperative analgesics in terms of postoperative abilities, PONV, pain and discharge time from the PACU

Conditions Studied

Cholecystolithiasis

Interventions

•Gabapentin
•S-ketamine
•Lidocaine
•Droperidol

Eligibility

Age:18 Years - N/A

Healthy Volunteers:No

View full eligibility criteria

Inclusion Criteria:

* Elective laparoscopic cholecystectomy
* Age above 18 years
* Written informed consent
* ASA class I-III

Exclusion Criteria:

* Planned abdominal cholecystectomy
* Intraoperative conversion of laparoscopic to laparotomic cholecystectomy
* Allergy to part of the treatment regimens
* Previous reactions to opioids (nausea, cognition)

Study Locations (1)

Dept of Anaesthesia, Hvidovre Hospital

Copenhagen, Hvidovre, Denmark